This study compares conventional and molecular techniques for the detection of fungi in 77 adult cystic fi brosis (CF) patients. Three different methods were investigated, i.e., (1) conventional microbiological culture (including yeasts and fi lamentous fungi), (2) mycological culture with CF-derived fungal specifi c culture media, and (3) Non-culture and direct DNA extraction from patient sputa. Fungi isolated from environmental air samples of the CF unit were compared to fungi in sputa from CF patients. Fungi ( n = 107) were detected in 14/77(18%) of patients by method 1, in 60/77 (78%) of patients by method 2 and with method 3, in 77/77(100%) of the patients. The majority of yeasts isolated were Candida albicans and C. dubliniensis . Exophiala ( Wangiella ) dermatitidis, Scedosporium apiospermum , Penicillium spp., Aspergillus fumigatus , and Aspergillus versicolor were also identifi ed by sequence analysis of the rDNA short internal transcribed spacer (ITS2) region. Conventional laboratory analysis failed to detect fungi in 63 patients mainly due to overgrowth by Gram-negative organisms. Mycological culture with antibiotics dramatically increased the number of fungi that could be detected. Molecular techniques detected fungi such as Saccharomyces cerevisiae , Malassezia spp., Fuscoporia ferrea , Fusarium culmorum , Acremonium strictum , Thanatephorus cucumeris and Cladosporium spp. which were not found with other methods. This study demonstrates that several potentially important fungi may not be detected if mycological culture methods alone are used. A polyphasic approach employing both enhanced mycological culture with molecular detection will help determine the presence of fungi in the sputa of patients with CF and their healthcare environment.
Introduction
The lungs of cystic fi brosis (CF) patients are often colonized or infected in infancy and early childhood with such organisms as Staphylococcus aureus and Haemophilus Trichosporon beigelii can also cause allergic bronchoplumonary mycosis [ 2, 3 ] . However, only Aspergillus spp. have been recognized as being associated with pulmonary symptoms in CF patients and there have been only a few reports of species other than members of this genus being of clinical signifi cance in CF patients. In addition, Aspergillus spp. and other fungi may be of particular importance in the context of CF lung transplantation. The incidence of all types of fungal infections in lung transplantation recipients is around 5-10%. Pulmonary aspergillosis is the most frequently observed fungal infectious complication of heart-lung or isolated lung transplantation and invasive fungal infection is often fatal, with the mortality rate following Aspergillus infection in such patients remaining around 70% [ 4 ] . Fatal invasive fungal infections due to Candida spp., Scedosporium spp. and Paecilomyces spp. in CF patients after lung transplantation are beginning to be reported [ 5 -7 ] .
Although fungal infections are associated with a higher mortality rate than either bacterial or viral infections, the presence of fungi in the airways of CF patients is often not considered as a signifi cant clinical criterion [ 8 ] . With improving methods for the detection of fungi, the prevalence and diversity of fungi in CF patients has been increasing in the last few years. According to the data from the Cystic Fibrosis Foundation, the occurrence rate of Aspergillus spp. in CF patient sputum samples has effectively doubled in the last decade (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) ) from 6% to 13%. Some studies have reported a correlation between antibiotic therapy and the increased occurrence of fungi [ 9 ] . However, despite interest and knowledge of bacterial lung infections, the prevalence, diversity, effects and symptoms of fungi in CF is still largely unknown.
The clinical signifi cance of fungal infection is not clear and increasing information on the topic is diffi cult due to the insensitivity of fungal culture methods. Yeasts and fi lamentous fungi may be present in CF sputum, as a result of three mechanisms, i.e., (i) co-incidental presence due to airborne introduction from the environment, or contamination of the oropharynx and mouth due to foodstuffs, (ii) colonization of the airways without any clinical sign, similar to the presence of a commensal organism; and (iii) pathogenic role in a disease process. Unlike the gastrointestinal tract, our understanding of their presence in a commensal-like fashion is limited as fungi should not be present in the airways. Although in the majority of the cases no clinical signs are associated with the recovery of fi lamentous fungi from sputum samples, one cannot disregard the fact that the development of these fungi (which cannot be considered as commensal organisms) in the airways may contribute to the infl ammatory reaction which progressively leads to the deterioration of the lung function in CF patients.
Although CF clinicians are now becoming more aware of the presence of fungi in sputum specimens of their patients, and are subsequently beginning to consider the clinical signifi cance of these organisms in patients, to date, there have been relatively few studies describing the ecological mycobiota of the CF lung, mainly due to a lack of reliable methods to undertake such studies. Although the application of molecular techniques to aid in the detection of fungi in clinical infection has been well studied and published, there has only been a single recent report to date, employing panfungal PCR techniques to detect fungi in sputa of CF patients [ 10 ] . Hence it was for these novel reasons that the current study was designed and performed. In addition, we were interested in determining the presence of other fungi recently reported in CF, including Scedosporium apiospermum and Exophiala dermatitidis . These two organisms are beginning to be reported with increasing frequency and pathogenicity [11] [12] [13] [14] [15] [16] [17] .
In order to determine the occurrence of fungi in CF sputum samples, this study compared conventional and PCR-based techniques for the detection of yeasts and fi lamentous fungi and investigated the prevalence and diversity of fungal species in sputa from 77 adult CF patients in Northern Ireland. Three different methods were compared to detect fungi in sputum, i.e., (1) conventional nonselective culture, (2) mycological culture with CF-derived fungal specifi c culture media, and (3) direct DNA extraction and fungal PCR from sputum. Contemporaneous environmental air samples were also taken from the cystic fi brosis unit to examine the prevalence of fungi in the environment and to compare this data to that obtained in the analysis of sputa from CF patients.
Materials and methods

Patients
Sputum samples from 77 individual adult (Ͼ18 years old; female 52% and male 48%) CF patients attending the Northern Ireland Regional Adult CF Centre, Belfast City Hospital, were collected over the 13 month study period, from December 2004-January 2006. Patients were selected consecutively on their ability to produce a sputum specimen in either an out-patient or in-patient setting. Each patient enlisted into the study had only one sputum specimen examined. The median age of CF patients examined was 28.5 years (range 18-59 years) and the majority of sputa from patients examined (68%) were obtained from those attending as out-patients for routine review or as a result of complications not requiring their admission. The remaining 32% of patients in the study were in-patients suffering from acute pulmonary exacerbation of their pulmonary condition. Sputum was collected from all England). This was in a room physically separated from that used to set up nucleic acid amplifi cation reaction mixes, and also from the 'post-PCR' room, in order to minimize contamination and the possibility of false positive results. Total genomic DNA (including fungal genomic DNA), was extracted directly from individual CF sputum samples in accordance with the following procedures. CF sputa were mixed with sterile Sputolysin (Calbiochem, La Jolla, CA, USA) in a ratio of 1:1 [v/v] and incubated for 15 min at 37°C. Following this, the sputum/sputolysin mixture was centrifuged at 13,000 g for 10 min. The supernatant was discarded and the pellet was resuspended in 200 ul Tris-HCl(10 mM, pH 8.0). Pelleted fungi were suspended in 1.5 ml Tris HCL (10 mM, pH 8.0) and were subjected to 6 cycles of freeze-thawing in liquid nitrogen/boiling. Genomic fungal DNA was further extracted from isolates employing the Roche High Purity PCR Template Preparation Kit (Roche Ltd., England), in accordance with the manufacturer's instructions. Extracted DNA was transferred to a clean tube and stored at −80°C prior to PCR studies. For each batch of extractions, negative extraction controls containing all reagents minus isolates, were performed. All reaction mixes were set up in a PCR hood in a room separate from that used to extract DNA and the amplifi cation and post-PCR room in order to minimize contamination.
For fungal identifi cation, DNA was amplifi ed with ITS1 and ITS4 PCR primer set targeting the 18S-ITS1-5.8S-ITS2-28S rRNA and internal transcribed spacer region [ 21 ] . For those samples that were negative by PCR with ITS1 and ITS4 (Ͻ10%), a nested PCR was performed with ITS3 and ITS4 PCR primer set targeting the 5.8S-ITS1-28S rRNA internal transcribed spacer region to improve sensitivity of fungal detection. PCR reaction mixes (50 μl) contained; 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 2.5 mM MgCl 2 , 200 μM (each) dATP, dCTP, dGTP and dTTP; 1.25U of Taq DNA polymerase (Amplitaq; Perkin Elmer), 0.2 μM (each) of the broad-range/universal interspacer (ITS) rDNA primers, ITS3/ITS4 [ 21 ] and 4 μl of DNA template, containing circa . 50ng DNA/ml extract. Following a 'hot start', the reaction mixtures were subjected to the following thermal cycling parameters in a Perkin Elmer 2400 thermocycler; 96°C for 3min followed by 40 cycles of 96°C for 1 min, 55°C for 1 min, 72°C for 1 min, followed by a fi nal extension at 72°C for 10 min. During each run molecular grade water (Biowhittaker Inc. Maryland, USA) instead of DNA was included randomly as a negative control and Candida albicans DNA, from a well-characterized wildtype strain, was included as a positive control.
Detection of amplicons
Following amplifi cation, aliquots (8 μl) were removed from each reaction mixture and examined by electrophoresis patients immediately after a standardized session of physiotherapy from a state-registered physiotherapist and all sputa were stored at ambient temperature, prior to microbiological processing.
Study design
Isolation and identifi cation of yeasts and fi lamentous fungi in sputa from these patients consisted of three components, namely:
(i) Non-selective conventional culture. Individual sputum samples were diluted 1:1 in Sputasol (Oxoid SR089A, Oxoid Ltd., Poole, England) and inoculated on Columbia blood agar base (Oxoid CM0331) supplemented with 5% [v/v] defi brinated horse blood (Oxoid SR0050) to be incubated at 37°C for 48 h. Isolated colonies of yeasts or fi lamentous fungi with distinct morphologies were examined to obtain their identifi cation at the species level. Yeasts were identifi ed biochemically using API ID 32C test strips (bioMérieux) or other biochemical identifi cation systems [ 18 ] , and fi lamentous fungi were identifi ed on the basis of their macroscopic and microscopic characters according to standard descriptions, as previously described [ 18 ] .
(ii) Mycological culture with CF-derived fungal specifi c culture media. Undiluted sputum samples were inoculated on two different fungal selective media, namely, Sabouraud dextrose agar (SDA) and Medium B + . SDA was obtained commercially from Oxoid Ltd, Basingstoke, UK (CM0041) and was prepared in accordance with the manufacturer's instructions. Medium B + was a novel fungal selective medium, which was developed specifi cally for the detection of fungi in sputum from CF patients [ 19 ] . The medium consisted of dextrose (16.7 g/l), yeast extract (30 g/l), peptone (6.8 g/l) and agar (20 g/l) and was supplemented with the following combination of antibiotics to suppress the growth of bacterial co-habitants of CF sputa, most notably the Gram-negative organisms, Pseudomonas aeruginosa and Burkholderia cenocepacia , as well as Staphylococcus aureus , including ceftazidime (32 mg/l), chloramphenicol (50 mg/l), colistin (24 mg/l) and cotrimoxazole (128 mg/l). All inoculated plates of both media were incubated aerobically at 22°C for three weeks. Following incubation, the identifi cation of fungal colonies with distinct morphologies was made by using rDNA PCR and sequencing techniques, as described below.
(iii) Direct DNA extraction from sputum and colonies and fungal rDNA PCR & sequencing. All DNA isolation procedures were carried out in accordance with the DNA contamination management guidelines of Millar et al . [ 20 ] and in a Class II Biological Safety Cabinet (MicroFlow, air at these locations, under normal hospital conditions, were sampled both qualitatively and quantitatively, employing an electrical slit air sampler (CF Casella Ltd., London, England), in accordance with the manufacturer's instructions. After thorough decontamination of the air slit sampler with absolute ethanol, the sampler was placed at each location and approximately 1,400 l of air for the specifi c location was drawn in for a 2 min period, over the microbiological agar media employed. For mycological examination, triplicate agar plates [diameter = 8 cm] (Sterilin Ltd., UK) of SDA (Oxoid CM0041) were employed. After incubation of the plates at 22°C for 2 weeks, all resulting yeasts and fi lamentous fungi were identifi ed employing rDNA PCR and direct sequencing techniques, as detailed above.
Conventional identifi cation of environmental fungal isolates
All fungal isolates were grown on SDA at both 22°C and 37°C, for the purposes of identifi cation. Resulting fi lamentous colonies were examined both macroscopically and microscopically, in terms of their colonial features, ability to grow at 22°C and 37°C, and microscopic characteristics, and identifi ed in accordance with previously published algorithms/criteria for the identifi cation of medically important fungi [ 18 ] .
Results
Sputum samples from 77 patients with CF were analysed and a total of 107 yeasts and fi lamentous fungi were identifi ed by using three different methods ( Table 2 ) . Candida spp. were detected in all but two patients (75/77, 97%). Of these, the most common was Candida albicans (45/77, 58%), followed by Candida dubliniensis (30/77, 39%), Candida parapsilosis (7/77, 9.1%) and Candida glabrata (4/77, 5.2%). Other yeasts such as Saccharomyces cerevisiae (5/77, 6.5%), Malassezia spp. (2/77, 2.6%), Trichosporon spp., (2/77, 2.6%), Rhodotorula sp.
(1/77, 1.3%) were also detected. The most common fi lamentous fungi found in sputum samples were Aspergillus spp. (7/77, 9.1%) including Aspergillus fumigatus (4/77, 5.2%) and Penicillium spp. (7/77, 9.1%), followed by Scedosporium apiospermum (3/77, 3.9%), Exophiala dermatitidis (3/77, 3.9%), Aureobasidium pullulans (1/77, 1.3%), Fuscoporia ferrea (1/77, 1.3%), Fusarium culmorum (1/77, 1.3%), Acremonium strictum (1/77, 1.3%), Thanatephorus cucumeris (1/77, 1.3%) and Cladosporium spp. (1/77, 1.3%).
Using conventional microbiological culture techniques, fungi were detected in only 14/77 (18%) patient samples, of which eight were Candida spp. (7.8%), including 2 Candida albicans (2.6%), 5 Aspergillus spp. (6.5%), including an (100V, 45 min) in gels composed of 2% (w/v) agarose (Gibco Ltd., Paisley, Scotland, UK) in TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA, pH 8.3) and stained with ethidium bromide (5 μg/100ml). Gels were visualized under UV illumination with a gel image analysis system (UVP Products Ltd., England) and all images were archived as digital graphic bitmap fi les (*.bmp).
Sequencing of rDNA PCR amplicons
PCR amplicons were identifi ed by both cloning and direct sequencing techniques. All amplicons were purifi ed using the QIA quick PCR purifi cation kit (QIAGEN Ltd., UK) eluted in molecular grade water, prior to sequencing, in order to remove dNTPs, polymerases, salts and primers. For samples in which fungal DNA was extracted from sputa and more than one band was detected by electrophoresis after PCR amplifi cation, the QIAGEN PCR cloning plus kit (QIAGEN Ltd., UK) was used in accordance with the manufacturer's instructions in order to separate all of the different amplifi ed fungal DNA. Following this, the plasmids including the target fungal DNA were extracted with QIAprep ® Spin Miniprep Kit (QIAGEN Ltd., UK) in accordance with the manufacturer's instructions.
Both PCR amplicons and cloned plasmids, including the target DNA, were sequenced by the ABI PRISM BigDye Terminator v3.1 Cycle Sequencing kit and ABI PRISM 3100 automated sequencer, according to the manufacturer's instructions. Appropriate primers ITS1, ITS3 (for the PCR amplicons) and -20 M13 forward (for the plasmids: 5´-GTAAAACGACGGCCAGTG-3´) were employed as sequencing primers. Resulting sequences were confi rmed from chromatogram analysis and confi rmed sequences were compared with those stored in the GenBank using the BLAST alignment software ( http:// www.blast.genome.ad.jp/ ). Sequence similarity was determined in accordance with criteria described previously [ 22 ] . Where a sequence from the short ITS region was not able to yield an identity to the species level, then the longer ITS region was recruited, as a means of improving the speciation. All short ITS sequences were subsequently submitted to GenBank and a corresponding accession number was issued.
Examination of indoor air from CF inpatient and outpatient environmental sites
Fifteen sites within the Regional Adult Cystic Fibrosis Centre, Belfast City Hospital were targeted for examination of the indoor air environment. These included the out-patient clinic and two different in-patient wards ( Pseudomonas aeruginosa and Burkholderia cenocepacia wards), as detailed in Table 1 . The mycological components of indoor . This increase is probably due to our better understanding of the disease and the manner in which we manage it, in particular, with new and improved antibiotic interventions. The introduction of improved antibiotic agents and the way in which they are effectively used in double or triple therapy, as well as in antibiotic cycling, has helped to address the requirement to help control chronic Gram-infections in CF patients, but has inadvertently created a niche where a diverse range of fungi may be found. Furthermore, we do not believe that this marked rise in fungal recovery is due to any signifi cant improvements in the methodologies and equipment used at primary diagnostic clinical microbiology laboratories, who support both adult and pediatric CF centers, as these have gone largely unchanged for the past decade. Conventional laboratory analysis employing Columbia Blood agar failed to detect fungi in 63 patients (82%). This is probably due to inappropriate culturing time (24-48 h), non-selective medium conditions and overgrowth by Gramnegative organisms, such as Pseudomonas aeruginosa and Burkholderia cenocepacia, as described previously [ 33, 34 ] . Selective mycological culture with antibiotics dramatically increased the number of fungi recovered by 60% (46 identifi ed, as well as a novel Helotiales-like genus. All these fungal isolates have been archived within the culture collection of the Northern Ireland Public Health Laboratory, Belfast City Hospital. None of these fungi were detected from patients' sputum and their closest phylogentic neighbours have been shown to be from the plant rhizosphere and leaf litter. None have been previously shown to cause infection in CF patients or other patient populations.
Mean quantitative counts of fungi in those hospital environmental sites most associated with adult CF patients did not exceed 7 CFU/m 3 room air, with the patients' room on the Pseudomonas aeruginosa inpatient ward being the most heavily contaminated, with a mean airborne fungal count of 6.8 CFU /m 3 room air ( Table 1 ) .
Six fungal species were detected in both patients' sputa, as well as in the air from either out-patient or in-patient environments and included A sp ergillus fumigatus , Aspergillus versicolor , Aureobasidium pullulans , Cladosporium spp., Penicillium spp. and Rhodotorula spp. ( Fig. 1 ) .
Most CF patients (46 patients; 60%) had only one fungal species detected in their sputa, 18 patients (23%) had two fungal taxa in their specimens, 12 (16%) had three fungal taxa and only one had fi ve fungal species present. Presence of multiple fungal species in CF sputa was detected by identifying one or more bands, following electrophoresis of the ITS3/TS4 PCR products, as shown ( Fig. 2 ) . The diversity of yeasts and fi lamentous fungi identifi ed in adult CF patients in Northern Ireland were compared with results in previous reports ( Table 2 ) . Candida albicans was detected with the highest prevalence rate (58%), which is in accordance with the data noted in the literature [35] [36] [37] . Candida dubliniensis was detected in 39% of patients as the second most frequent fungus associated with in CF sputum samples. This prevalence rate was significantly higher than the reported highest prevalence rate which is 11.1% [ 38 ] . This could be due to the misidentifi cation of this yeast as Candida albicans , since both species share many morphological and physiological characteristics. Consequently, our investigation demonstrates the great effi cacy of identifi cation by sequence analysis of the rRNA gene ITS regions. Candida glabrata and Trichosporon spp. were also detected with a slightly higher prevalence rate than the reported rate [ 15 ,35 ] . The prevalence of Exophiala dermatitidis , Penicillium spp., Scedosporium apiospermum and Cladosporium spp. were in accord with results in previous reports [ 6, 15, 26, 35, 39 ] . Interestingly, Aspergillus spp. including Aspergillus fumigatus were detected at a lower rate (9.1%) as compared with the data in the literature [ 15 ] . To the best of our knowledge, this is the fi rst report describing the isolation of Rhodotorula spp., Saccharomyces cerevisiae , Aureobasidium pullulans , Fuscoporia ferrea , Fusarium culmorum , Acremonium strictum , Malassezia spp. and Thanatephorus cucumeris in CF patient sputa. However, employment of the direct DNA extraction-PCR-sequencing method was problematic at times. For instance, this method was unable to detect Aspergillus fumigatus in four CF patient specimens (see Table 2 ), which were detected employing a culture + molecular identifi cation system (Method 2). This may be due to the inhibition of PCR methods in the presence of CF sputum, which has been demonstrated previously to be inhibitory to nucleic acid amplifi cation [ 40 ] . Additionally, the numbers of fungal organisms may have been low and hence have gone undetected by Method 3.
Six fungal taxa were detected in both patients' sputa and in the air from either out-patient or in-patient environments and included Aspergillus fumigatus , Aspergillus versicolor , Aureobasidium pullulans , Cladosporium spp., Penicillium spp. and Rhodotorula spp. The chronology cannot be determined regarding acquisition of these fungi in patients and their environment. Many of these fungi are the normal mycobiota of the hospital environment. However, although there have been numerous studies looking at the environmental bacterial loading (including air) of CF hospital inpatient and out-patient settings, there has been limited work on the presence of moulds and yeasts. In our study, the numbers of fungi recovered were relatively lower than those detailed in other studies [41, 42] . We found that the numbers of fungi recovered from air in the out-patient patients). This method was the most effective for the detection of E. dermatitidis , Rhodotorula spp., Aspergillus spp. and Aureobasidium pullulans . The direct extraction of DNA from sputum specimens (i.e., direct DNA extraction) was the most effective procedure for the detection of fungi among three different methods employed in this study. Through the use of direct DNA extraction, fungi were noted in all patient samples examined. In addition, Saccharomyces cerevisiae , Malassezia sp., Fuscoporia ferrea , Fusarium culmorum , Acremonium strictum , Thanatephorus cucumeris and Cladosporium sp. were identifi ed with only this method. With regard to method 2, we incubated specimens at 22°C for a prolonged period of 2 weeks. This was based on our desire to capture any environmental fungi that might be present in the sputa which could not grow at body temperature, but may be responsible for an allergic ABPA-type immunological response. Equally, we believe that this lower incubation temperature for the extended period of incubation would allow fungi that normally proliferate optimally at body temperature to grow and be detected/identifi ed.
Overall, the results of the comparison of three different methods for the detection of fungi in this study suggest the importance of including appropriate fungal culture media with a selective antibiotic combination in the routine microbiological analysis of respiratory secretions from CF patients. Non-culture and direct DNA extraction from sputa approach was valuable as it gave a high degree of sensitivity and speed for the detection of fungi and thus should be considered as an appropriate alternative to conventional mycological culture methods. mycological culture methods are not refi ned in order to select out genera that require additional workup. A polyphasic approach employing both enhanced mycological culture combined with molecular (rDNA) detection and identifi cation will serve to help determine the presence of these in the sputum of patients with CF and their healthcare environment.
In conclusion, this study identifi ed many different fungal species, which have not been described in the context of CF until this study, thus highlighting the diversity of the fungal biota associated with the CF lung. Further molecular and cellular work is now required in order to estimate the signifi cance of these organisms in this patient population. of the late Mr John (Jackie) McCaughern, for the purposes of pursuing microbiological investigations into the sources and transmission of microbial aetiologic agents of CF infection.
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The authors report no confl icts of interest. The authors alone are responsible for the content and writing of the paper. environments ranged from 0.7-2.5 CFU/m 3 and from 1.4-6.8 CFU/m 3 , for the in-patient wards. This difference in the data from our study and those reported in previous studies [ 41, 42 ] may be caused by variations of sampling circumstances and nature of the microbiological aerocontamination, as well as sampling instrumentation, as has been noted previously [ 43 ] .
Future studies should attempt to examine similar fungi isolated from both CF sputum and the air in CF wards/ out-patient settings, for the presence of common genotypes, before any association can be suggested, as to the risk of hospital air for the acquisition of such fungal species. Regardless, these studies demonstrated that the air in the immediate environment in which CF patients are present, is positive for viable fungi.
With regard to the clinical signifi cance of the yeasts and fi lamentous fungi that were detected from the CF patients in this study, a classifi cation scheme has been proposed in an attempt to group these into an order of importance ( Table 3 ) . CF physicians should be mainly concerned with fungi in Category I, as these have been described in several previous reports as being important pathogens in CF patients. What remains unclear, is the signifi cance of fungi described in Category II and therefore further work should be conducted to examine the clinical status of large numbers of patients from whom these organisms have been detected. In addition, studies should examine the in vitro virulence of these organisms including the examination of the pro-infl ammatory affect of these fungal taxa in the presence of CF lung epithelium.
Overall, in this study, we have demonstrated that several potentially important fungi may be missed if 
